Great article again :) Your analysis on the role of pharmaceutical industries logics is pretty accurate I think. I didn't know about the term "antibiotic stewardship" but this seems like a good way to mitigate current risks.
Maybe you heard about Eligo, it's a french start-up developing CRISPR vectors for targeted bacteria killing. The technology is still far from bedside but it could completely change the field.
You are viewing a single comment's thread from:
I hadn't hear about Eligo, no, seems like a project with a lot of potential.
Antibiotic sewardship really works at the other end of the problem, telling doctors when and how they can use antibiotics so that we prevent the evolution of bacterial resistance. It's very successful but unfortunately not very fun :P